Development of new geographic atrophy in patients with neovascular (wet) age-related macular degeneration: A comparison of ranibizumab and aflibercept.
A not for profit organisation
A not for profit organisation
Development of new geographic atrophy in patients with neovascular (wet) age-related macular degeneration: A comparison of ranibizumab and aflibercept.
If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.
